Whippany, NJ (July 27, 2006) - Image Solutions Inc., (ISI) a global technology company and a leader in providing software solutions and services for electronic regulatory document submission and clinical trials management, announced today the successful completion of their first eCTDXPress Aspire™ implementation for NeurogesX, a privately held, emerging pharmaceutical company based in the San Francisco Bay Area. eCTDXPress Aspire™ is ISI’s “out of the box” eSubmission solution designed specifically for growing Biotech and small Pharmaceutical organizations that need to file electronic submissions such as Investigational New Drugs (INDs), Biologic applications (BLAs), New Drug Applications (NDAs), abbreviated NDA’s (aNDAs), New Drug Submissions (NDS), and Marketing Authorization Applications (MAAs) in the electronic Common Technical Document (eCTD) format.
